METASTATIC PROSTATE CARCINOMA
Clinical trials for METASTATIC PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can switching PARP inhibitors outsmart cancer? new trial aims to find out
Disease control Recruiting nowThis study is testing a drug called talazoparib in people with advanced solid tumors that have specific DNA repair gene mutations. The goal is to see if this PARP inhibitor can shrink tumors or slow their growth, even in patients who have already tried a similar drug. About 36 ad…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:34 UTC
-
PET scans guide new combo therapy to fight returning prostate cancer
Disease control Recruiting nowThis study is for men whose prostate cancer has returned after surgery, shown by a rising PSA level. It tests whether adding a stronger drug combination (apalutamide plus abiraterone and prednisone) to standard radiation and hormone therapy can better control the cancer. For thos…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
Engineered immune cells take on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-phase trial tests a new treatment for men with a type of advanced prostate cancer that no longer responds to hormone therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. Some participants will als…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New trial aims to boost prostate cancer treatment with targeted radiation
Disease control Recruiting nowThis study tests whether adding radiation therapy guided by a special PET scan to standard hormone therapy can help men with prostate cancer that has spread. About 125 men will be randomly assigned to receive either standard treatment alone or standard treatment plus radiation to…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Testosterone therapy shows promise for Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-phase study tests a treatment called bipolar androgen therapy for men with advanced prostate cancer that no longer responds to standard hormone therapy and has spread. The approach rapidly switches testosterone levels from very low to very high to shock cancer cells an…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Exercise program aims to fight frailty in prostate cancer patients
Symptom relief Recruiting nowThis study tests whether a 16-week supervised exercise program (combining resistance, functional, and aerobic training) can improve frailty and muscle loss in 80 men with metastatic prostate cancer who are on hormone therapy. Participants must be pre-frail or frail. The goal is t…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 26, 2026 03:34 UTC
-
Could home cancer care be just as safe and more satisfying for black men?
Symptom relief Recruiting nowThis study looks at whether giving cancer therapy at home instead of in a clinic can improve the experience for Black men with advanced prostate cancer. About 38 participants will try both home and clinic treatments to compare safety, side effects, and satisfaction. The goal is t…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 02:48 UTC
-
Bright light may lift mood and energy in prostate cancer patients
Symptom relief Recruiting nowThis study tests whether using bright white light therapy glasses can reduce fatigue and improve mood in men with advanced prostate cancer who are on hormone therapy. About 210 men will either start light therapy right away or wait a few months. The goal is to help patients feel …
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Freezing tumors may boost radiation pain relief for bone metastases
Symptom relief Recruiting nowThis study tests whether adding cryoablation (freezing cancer cells) to standard radiation therapy provides better pain relief for people with cancer that has spread to the bones. About 40 adults with certain advanced cancers (like prostate, kidney, or colorectal) will be enrolle…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
Peer coaches aim to close genetic testing gap for black men with prostate cancer
Knowledge-focused Recruiting nowThis study looks at whether a network of peer genetic coaches can help African American men with metastatic prostate cancer overcome barriers to genetic testing. The coaches will provide education and support to increase awareness and navigation. The goal is to see if this approa…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated May 26, 2026 03:29 UTC
-
Peer navigators may close genetic testing gap for black men with prostate cancer
Knowledge-focused Recruiting nowThis study looks at whether having a trained peer navigator—someone who guides patients through the process—helps African American men with advanced prostate cancer better understand and complete genetic testing. Genetic testing is important for treatment decisions, but many Afri…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated May 26, 2026 03:28 UTC
-
Can DNA glitches predict prostate cancer treatment success?
Knowledge-focused Recruiting nowThis study looks at men with advanced prostate cancer that has spread to the bones. Researchers want to see if certain DNA repair problems make the drug radium-223 work better. About 48 men will take part, and their response will be measured by blood tests. The goal is to help do…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 26, 2026 03:28 UTC
-
Biopsies reveal secrets of prostate cancer resistance
Knowledge-focused Recruiting nowThis study looks at why some prostate cancers become resistant to a treatment called 177Lu-PSMA, which delivers radiation directly to cancer cells. Researchers will take small tissue samples (biopsies) from tumors in 30 men with advanced prostate cancer that has spread. The goal …
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
Talking computer could boost genetic testing for underserved cancer patients
Knowledge-focused Recruiting nowThis study tests whether a computer-generated character can effectively educate cancer patients about genetic testing, compared to a human genetics counselor. The goal is to see if this approach increases testing rates, especially for minority and rural patients who often lack ac…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC
-
Vitamin d study seeks to unlock immune secrets in black prostate cancer patients
Knowledge-focused Recruiting nowThis study looks at how common low vitamin D levels are in African American men with prostate cancer, and whether correcting those levels can improve immune function. Researchers will measure vitamin D and immune cells in blood samples before and after supplementation. The goal i…
Matched conditions: METASTATIC PROSTATE CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC